CLINICAL EFFICACY OF THE RIBVD REGIMEN FOR REFRACTORY/RELAPSED (R/R) MANTLE CELL LYMPHOMA (MCL) PATIENTS: A RETROSPECTIVE STUDY OF THE LYSA GROUP
Regny, C., Oberic, L., guillaume, M., Malak, S., Sarkozy, C., Clavert, A., Herbaux, C., Chauchet, A., jourdan, E., Sanhes, L., Godmer, P., Pascal, L., Le Du, K., Voilat, L., Dupuis, J., Beauchard, S.,Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000560228.52872.e9
Date:
June, 2019
File:
PDF, 307 KB
2019